Urban Food Access Impact in Washington, D.C.'s Communities
GrantID: 13907
Grant Funding Amount Low: $350,000
Deadline: Ongoing
Grant Amount High: $350,000
Summary
Explore related grant categories to find additional funding opportunities aligned with this program:
Health & Medical grants, Research & Evaluation grants, Science, Technology Research & Development grants.
Grant Overview
Priority Outcomes for Washington, DC Investigator-Initiated Mid-Phase Clinical Trials of Natural Products Grants
Washington, DC is a hub for biomedical research, with numerous institutions and organizations driving innovation in the field. For the Grants for Cooperative Agreement Applications for Investigator-Initiated Mid-Phase Clinical Trials of Natural Products, the priority outcomes are closely tied to the region's unique strengths and challenges. The DC Department of Health, a key state agency, plays a crucial role in shaping the healthcare landscape and identifying areas of need.
One of the primary priority outcomes for this grant is the advancement of research on natural products with potential therapeutic applications. Washington, DC is home to a diverse range of research institutions, including universities and hospitals, which are well-positioned to conduct high-quality clinical trials. The city's dense network of research organizations and its proximity to federal funding agencies make it an ideal location for collaborative research initiatives. The grant office in Washington, DC is equipped to support applicants through the application process, providing guidance on federal grants department procedures and best practices.
Targeting Key Research Areas in Washington, DC
The District of Columbia's unique demographic features, including its diverse population and high prevalence of certain health conditions, make it an ideal location for research on natural products. For example, the city's high rates of hypertension and cardiovascular disease create a pressing need for innovative treatments. Researchers in Washington, DC are well-positioned to investigate the potential therapeutic benefits of natural products in addressing these health concerns. Small business grants in Washington, DC can also support the development of new products and therapies.
To achieve the priority outcomes for this grant, researchers will need to focus on areas such as the development of novel therapeutic agents, the investigation of natural product extracts, and the evaluation of traditional medicine practices. By targeting these key research areas, investigators can capitalize on the region's strengths and address pressing health needs. Grants in Washington, DC for research on natural products can help drive progress in these areas.
Measuring Success in Washington, DC
The success of the Grants for Cooperative Agreement Applications for Investigator-Initiated Mid-Phase Clinical Trials of Natural Products in Washington, DC will be measured by the progress made towards the priority outcomes. Key metrics will include the number of clinical trials conducted, the number of promising therapeutic agents identified, and the impact of the research on public health outcomes. The DC Department of Health and other regional bodies will play a key role in tracking and evaluating the outcomes of the research. By monitoring these metrics, stakeholders can assess the effectiveness of the grant program and identify areas for improvement. The district's grant department will also be involved in evaluating the success of the grants program.
Q: What are the key research areas being targeted by the Grants for Cooperative Agreement Applications for Investigator-Initiated Mid-Phase Clinical Trials of Natural Products in Washington, DC? A: The key research areas being targeted include the development of novel therapeutic agents, the investigation of natural product extracts, and the evaluation of traditional medicine practices.
Q: How will the success of the grant program be measured in Washington, DC? A: The success of the grant program will be measured by the progress made towards the priority outcomes, including the number of clinical trials conducted, the number of promising therapeutic agents identified, and the impact of the research on public health outcomes.
Q: What resources are available to support applicants for the Grants for Cooperative Agreement Applications for Investigator-Initiated Mid-Phase Clinical Trials of Natural Products in Washington, DC? A: The grant office in Washington, DC provides guidance and support to applicants, and the DC Department of Health is a key partner in shaping the healthcare landscape and identifying areas of need. Additionally, small business grants in Washington, DC can support the development of new products and therapies.
Eligible Regions
Interests
Eligible Requirements
Related Searches
Related Grants
Grants for Community Safety Alternatives for Testing New Solutions for High-Needs Areas
Grant to explore and test new approaches to community safety and trust-building in neighborhoods wit...
TGP Grant ID:
65128
Grants to Sustainable Improvements in a Jurisdiction's Research Infrastructure
Grant to build research capacity in institutions and transform the career trajectories of investigat...
TGP Grant ID:
56595
Grants for Oral Health Care for Vulnerable Populations
This grant alleviates financial burdens and enables providers to continue offering vital dental serv...
TGP Grant ID:
72207
Grants for Community Safety Alternatives for Testing New Solutions for High-Needs Areas
Deadline :
2024-07-08
Funding Amount:
$0
Grant to explore and test new approaches to community safety and trust-building in neighborhoods with high rates of low-level offenses. The grant aims...
TGP Grant ID:
65128
Grants to Sustainable Improvements in a Jurisdiction's Research Infrastructure
Deadline :
Ongoing
Funding Amount:
$0
Grant to build research capacity in institutions and transform the career trajectories of investigators and further develop their individual research.
TGP Grant ID:
56595
Grants for Oral Health Care for Vulnerable Populations
Deadline :
2025-03-18
Funding Amount:
Open
This grant alleviates financial burdens and enables providers to continue offering vital dental services to those in need. It focuses on enhancing acc...
TGP Grant ID:
72207